Lumic
NIFTY 50·22,888.95−1.11%SENSEX·73,852.90−1.17%BANK NIFTY·55,488.10−0.64%RELIANCE·1,202.00−0.76%HDFC BANK·712.00−2.31%ICICI BANK·1,381.00−1.15%BHARTI AIRTEL·1,875.20−1.56%INFOSYS·1,130.70−2.63%L&T·3,661.90+0.96%TCS·2,460.90−0.17%ITC·260.80−1.02%SBI·973.70+1.15%AXIS BANK·1,236.00−4.19%NIFTY 50·22,888.95−1.11%SENSEX·73,852.90−1.17%BANK NIFTY·55,488.10−0.64%RELIANCE·1,202.00−0.76%HDFC BANK·712.00−2.31%ICICI BANK·1,381.00−1.15%BHARTI AIRTEL·1,875.20−1.56%INFOSYS·1,130.70−2.63%L&T·3,661.90+0.96%TCS·2,460.90−0.17%ITC·260.80−1.02%SBI·973.70+1.15%AXIS BANK·1,236.00−4.19%

Nifty

Nifty Gainers & Losers 31st August: RBI Support Meets MSCI Rebalancing

about 2 months ago · Lumic

Nifty 50 stock chart showing gains and losses, with icons representing RBI and MSCI.
Lumic
about 2 months ago
Nifty Gainers & Losers 31st August: RBI Support Meets MSCI Rebalancing
KEY POINTS
Pharma stocks led gains as a steadier rupee can help lower costs for imported inputs
Sun Pharma gained 3.38%, leading Nifty as currency stability supported importers
Adani stocks fell sharply as MSCI rebalancing flows drove heavy closing-auction moves
LUMIC INSIGHT
Rupee stability can benefit pharma by easing import costs
NSE·about 2 months ago

This Fin Shorts report dives into the Nifty 50's performance on August 31st, where key market movements were influenced by two significant factors: RBI support for the rupee and the MSCI rebalancing event. We explore how a steadier rupee positively impacted pharma stocks, with Sun Pharma showing strong gains as lower import costs benefit the sector. Conversely, Adani stocks like Adani Enterprises and Adani Ports experienced sharp declines, largely due to selling pressure driven by MSCI India rebalancing and the closing auction system. This analysis touches upon passive fund flows and how foreign investors react to such market events, contributing to stock market volatility. Understand the interplay between central bank actions and global index adjustments in the Indian stock market.

More in Nifty